Ken Griffin
PHAR

Ken Griffin’s Pharming Group PHAR Stock Holding History

Ken Griffin’s Portfolio PHAR Stock Details PHAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$170K Sell
10,189
-7,501
-42% -$127K ﹤0.01% 11577
2025
Q4 		$313K Buy
+17,690
New +$278K ﹤0.01% 10043

Other funds holding PHAR

SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SHIM
Stone House Investment Management Tunkhannock, Pennsylvania $752M AUM 20.1% 1-Year Est. Return

Ken Griffin's PHAR Position: Q1 2026 in Review

Ken Griffin reduced its Pharming Group (PHAR) stake by 42% in Q1 2026, selling an estimated $127K and leaving 10,189 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #11577.

Ken Griffin first reported a position in PHAR in Q4 2025 and has held it in 2 quarters since. The position peaked at $313K in Q4 2025. 12 funds tracked by Wall St. Rank hold PHAR as of Q1 2026.

  • Ken Griffin held 10,189 shares of Pharming Group worth $170K as of Q1 2026.
  • Ken Griffin sold 7,501 Pharming Group shares in Q1 2026, an estimated $127K.
  • Pharming Group made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #11577 holding.
  • Ken Griffin first reported a position in Pharming Group in Q4 2025 and has held it in 2 quarters since.
  • Ken Griffin's Pharming Group position peaked at $313K in Q4 2025.
  • 12 funds tracked by Wall St. Rank held Pharming Group as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.